Phase 4 Obesity Trial, Recruiting NCT06986993 Sponsor: University of Oklahoma Condition: Obesity
Back to Obesity

Phase 4 Obesity Trial, Recruiting

NCT06986993
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old
  • People who smoke more than 2 cigarettes per day on a daily basis
  • People who have a Body Mass Index (BMI) of 30 or higher, which is the medical threshold for obesity
  • People who do not currently want to quit smoking

Who may not be able to join:

  • People who have ever been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder
  • People who have been admitted to a hospital for psychiatric reasons in the past year
  • People who have had thoughts of suicide in the past month, any suicide attempt in the past year, or who show signs of severe depression based on screening questionnaires
  • People whose depression or anxiety symptoms have been getting worse over the past 3 months
  • People with a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma) or a hormonal condition called multiple endocrine neoplasia syndrome
  • People with a personal history of pancreas inflammation (pancreatitis), type 1 or type 2 diabetes, a diabetes-related eye condition, or a stomach-emptying disorder
  • People currently using any nicotine replacement products (such as patches or gum) or any prescription medication to help with quitting smoking
  • People who have previously had weight-loss (bariatric) surgery
  • People who have used a GLP-1 medication (a type of drug used for weight loss or blood sugar control) or any other weight-lowering or blood sugar-lowering medication in the past 6 months — this includes medications such as metformin, insulin, and several others (confirm with trial site for the full list)
  • People whose blood test results fall outside acceptable ranges, including measures related to kidney function, liver function, blood fats, blood sugar, or other laboratory values that the study doctor considers significantly abnormal
  • People with a significant bowel or digestive condition, such as inflammatory bowel disease, certain bowel cancers, severe stomach-emptying problems, bowel obstructions, or a history of bowel surgery (some minor surgeries such as appendix removal may be acceptable — confirm with trial site)
  • People with any other health condition or circumstance that the study investigators believe would make participation unsafe or interfere with the study
  • People with a known or suspected allergy to semaglutide (the study drug) or any related medications

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 405-271-1903

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
University of Oklahoma
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
30 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cigarette smoking

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov